Radiation Oncology/Therapy: Page 240

Peptide therapy reduces tumor size, side effects
By AuntMinnie.com staff writers
Dutch researchers are reporting on a peptide receptor radiolabeled therapy that can decrease both tumor size and the severity of side effects in cancer patients in this month's issue of the Journal of Nuclear Medicine.
September 20, 2011
Varian makes bid to acquire Calypso
By AuntMinnie.com staff writers
Radiation therapy vendor Varian Medical Systems has inked a definitive agreement to acquire electromagnetic localization technology developer Calypso Medical Technologies.
September 18, 2011
GE event assembles investors, advocates to fight cancer
By Cynthia E. Keen
NEW YORK CITY - GE Healthcare today upped the ante in its war on cancer, assembling a star-studded field of public health advocates and venture capitalists to announce a new round of investments to accelerate innovation in cancer detection and therapy.
September 14, 2011
Elekta completes Nucletron purchase
By AuntMinnie.com staff writers
Oncology firm Elekta announced it has completed its acquisition of radiation therapy firm Nucletron for 365 million euros ($522.1 million U.S.) in cash.
September 14, 2011
GE to invest $1B in new oncology R&D
By AuntMinnie.com staff writers
GE Healthcare has announced plans to dedicate $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging offerings, as well as technologies for manufacturing biopharmaceuticals and for cancer research.
September 14, 2011
iCAD stock price below Nasdaq minimum
By AuntMinnie.com staff writers
Computer-aided detection (CAD) firm iCAD has received a letter from the Nasdaq stock market informing the company that the bid price for its common stock has closed below the minimum $1 per share requirement for the past 30 consecutive business days.
September 12, 2011
Elekta gets OK for Nucletron buy
By AuntMinnie.com staff writers
Oncology firm Elekta has obtained regulatory approval for its proposed acquisition of radiation therapy firm Nucletron for 365 million euros ($522.1 million U.S.) in cash.
September 12, 2011
.decimal gets FDA OK for electronic aperture
By AuntMinnie.com staff writers
Radiation therapy device manufacturer .decimal has received 510(k) clearance from the U.S. Food and Drug Administration to market electron apertures for use with radiation treatment systems from Varian Medical Systems.
September 12, 2011
Proton therapy experts look back and to the future
By Tami Freeman
Proton therapy as a cancer treatment has been making gains, but it's years away from becoming mainstream. What's happened over the past five years? Medicalphysicsweb takes a look at the evolution of this intriguing form of cancer treatment.
September 11, 2011
2009 01 15 16 03 49 510 Med Phys Web Logo 100
FDA offers guidance to device importers
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration has published a new document that offers guidance to companies importing electronic devices into the U.S. that emit radiation.
September 8, 2011
Concurrent chemo + RT improves survival for inoperable NSCLC
By Cynthia E. Keen
Chemotherapy delivered concurrently with radiation therapy (RT) is more effective than treatments delivered sequentially for extending the lives of patients with inoperable stage III non-small cell lung cancer (NSCLC), according to a study published online September 8 in the Journal of the National Cancer Institute.
September 8, 2011
Segasist highlights autocontouring software
By AuntMinnie.com staff writers
Imaging software developer Segasist Technologies will showcase its Reconcillio automated image contouring software at the American Society for Radiation Oncology annual meeting in October in Miami Beach, FL.
September 7, 2011
Previous Page
Page 240 of 468
Next Page